Clinical Trial Update: Trimodal Lung-Sparing Treatment of Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial update on trimodal, lung-sparing treatment for pleural mesothelioma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Mesothelioma

Snippet

Sponsor: Columbia University | Conditions: Pleural Mesothelioma | Phase 2 | Status: TERMINATED | Results posted: 2020-08-25